Neoadjuvant Chemotherapy Shortens the cfDNA Telomere Length in Breast Cancer Patients

Neoadjuvant Chemotherapy Shortens the cfDNA Telomere Length in Breast Cancer Patients

Conclusion: Our study suggests that telomere length in cfDNA may be a useful biomarker for predicting therapy response and possible reoccurrence of the disease in breast cancer patients.

Bibliographische Detailangaben
Hauptverfasser:	İrem Peker Eyüboğlu, Sinan Koca, Betül Çelik, Gökçe Güllü Amuran, M. Ümit Uğurlu, Özkan Alan, Tuğba Akın Telli, Perran Fulden Yumuk, Mustafa Akkiprik
Format:	Artikel
Sprache:	English
Veröffentlicht:	Wiley 2024-01-01
Schriftenreihe:	International Journal of Breast Cancer
Online Zugang:	http://dx.doi.org/10.1155/2024/6117394

Ähnliche Einträge

New Insights in Bladder Cancer Diagnosis: Urinary miRNAs and Proteins
von: Gökçe Güllü Amuran, et al.
Veröffentlicht: (2018-12-01)

A simple and cost-effective real-time PCR method using diluted and heat-treated whole blood lysate
von: Gökçe Güllü Amuran, et al.
Veröffentlicht: (2024-11-01)

The cfDNA in early cancer detection
von: Hussein Adil Abid, et al.
Veröffentlicht: (2024-01-01)

Exploration of cfDNA landscape in NIPT and clinical utilities of cfDNA based gene expression inference in prenatal diagnostics
von: Ruo Jia, et al.
Veröffentlicht: (2025-02-01)

Diagnostic Value of cfDNA in Pancreatic Cancer
von: XU Yijun, et al.
Veröffentlicht: (2022-12-01)

Microfluidic Technologies for cfDNA Isolation and Analysis
von: Zheyun Xu, et al.
Veröffentlicht: (2019-10-01)

cfDNA Sequencing: Technological Approaches and Bioinformatic Issues
von: Elodie Bohers, et al.
Veröffentlicht: (2021-06-01)

Combinatorial Power of cfDNA, CTCs and EVs in Oncology
von: Corinna Keup, et al.
Veröffentlicht: (2022-03-01)

Identification of osimertinib-resistant EGFR L792 mutations by cfDNA sequencing: oncogenic activity assessment and prevalence in large cfDNA cohort
von: Stephen R. Fairclough, et al.
Veröffentlicht: (2019-10-01)

Impact of Liquid Biopsy Preanalytics on cfDNA Fragmentation Analyses
von: A. Hallermayr, et al.
Veröffentlicht: (2023-11-01)

What fraction of cellular DNA turnover becomes cfDNA?
von: Ron Sender, et al.
Veröffentlicht: (2024-02-01)

cfDNA in pancreatic neuroendocrine carcinoma management with Cushing’s syndrome
von: Laura Gerard, et al.
Veröffentlicht: (2023-01-01)

Comparison of the source and prognostic utility of cfDNA in trauma and sepsis
von: Nicholas L. Jackson Chornenki, et al.
Veröffentlicht: (2019-05-01)

Fragmentomic cfDNA Patterns in Noninvasive Prenatal Testing and Beyond
von: Kavish Kohabir, et al.
Veröffentlicht: (2021-04-01)

Somatic Mutation Calling from cfDNA Using Machine Learning
von: S. Akbarinejad, et al.
Veröffentlicht: (2023-11-01)

Epigenetic modifications of cfDNA in liquid biopsy for the cancer care continuum
von: Jodie Wong, et al.
Veröffentlicht: (2025-02-01)

Brave new world of cfDNA-omics for early cancer detection
von: Alessandro Russo, et al.
Veröffentlicht: (2023-09-01)

Plasma cfDNA in Carcinoma of unknown primary: A case series
von: Rajat Thawani, et al.
Veröffentlicht: (2024-03-01)

cfDNA Methylation Profiles and T-Cell Differentiation in Women with Endometrial Polyps
von: Xiao-Hong Li, et al.
Veröffentlicht: (2022-12-01)

Use of Internal Standards to Develop Improved Methylation Detection in cfDNA
von: Erin L> Crawford
Veröffentlicht: (2023-05-01)

Plasma cfDNA methylation markers for the detection and prognosis of ovarian cancer
von: Leilei Liang, et al.
Veröffentlicht: (2022-09-01)

Hypertensive disorders of pregnancy share common cfDNA methylation profiles
von: Marialuigia Spinelli, et al.
Veröffentlicht: (2022-11-01)

The utility of cfDNA in TGCT patient management: a systematic review
von: Jure Krasic, et al.
Veröffentlicht: (2022-05-01)

Deep cfDNA fragment end profiling enables cancer detection
von: Yulia V. Zhitnyuk, et al.
Veröffentlicht: (2022-01-01)

The Prognostic and Predictive Value of DR-70 Immunoassay, A Novel Fibrin-Associated Biomarker, in Patients with Advanced Gastrointestinal Cancers
von: Tuğba AKIN TELLİ, et al.
Veröffentlicht: (2022-03-01)

Preservation of cfRNA in cytological supernatants for cfDNA & cfRNA double detection in non‐small cell lung cancer patients
von: Yidan Ma, et al.
Veröffentlicht: (2024-09-01)

Impact of cfDNA Input on Enzymatic Methylation Conversion and Library Preparation Robustness
von: U. Kunej, et al.
Veröffentlicht: (2023-11-01)

Diagnostic Performance of Gene Expression and dd-cfDNA in Multiorgan Transplant Recipients
von: Ziad S. Zaky, MD, MBA, et al.
Veröffentlicht: (2025-03-01)

Methylation pattern of caveolin-1 in prostate cancer as potential cfDNA biomarker
von: Lucija Škara, et al.
Veröffentlicht: (2023-01-01)

The use of cell free DNA (cfDNA) for mutational screening of multiple myeloma
von: A-M Joëlle Marivel, et al.
Veröffentlicht: (2023-01-01)

Evaluation of cfDNA as an early detection assay for dense tissue breast cancer
von: Mouadh Barbirou, et al.
Veröffentlicht: (2022-05-01)

Performance of Streck cfDNA Blood Collection Tubes for Liquid Biopsy Testing.
von: Inga Medina Diaz, et al.
Veröffentlicht: (2016-01-01)

Beyond the Blood: CSF-Derived cfDNA for Diagnosis and Characterization of CNS Tumors
von: Abbye E. McEwen, et al.
Veröffentlicht: (2020-02-01)

Erratum to “The utility of cfDNA in TGCT patient management: a systematic review”
Veröffentlicht: (2022-06-01)

Accelerated Telomere Shortening in Acromegaly; IGF-I Induces Telomere Shortening and Cellular Senescence.
von: Ryusaku Matsumoto, et al.
Veröffentlicht: (2015-01-01)

Revisiting Telomere Shortening in Cancer
von: Keiji Okamoto, et al.
Veröffentlicht: (2019-01-01)

Exploring the clinical utility of liquid biopsy with cfDNA in cancer: A systematic review
von: Keerthi Ranganathan, et al.
Veröffentlicht: (2024-09-01)

Plasma cfDNA VILL gene methylation as a diagnostic marker for nasopharyngeal carcinoma
von: Xiao-Yan Fu, et al.
Veröffentlicht: (2025-02-01)

22: A case of partial trisomy 13 not detected on prenatal cfDNA screen
von: Laura Bryant, et al.
Veröffentlicht: (2025-01-01)

Early detection of uterine corpus endometrial carcinoma utilizing plasma cfDNA fragmentomics
von: Jing Liu, et al.
Veröffentlicht: (2024-07-01)